Skip to search formSkip to main contentSkip to account menu

Plenaxis

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

abarelix

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Prostatakarzinom: Wer profitiert von GnRH-Antagonisten?
Ob und bei welchen Patienten die GnRH-Blocker die bislang mit Erfolg verwendeten GnRH-Agonisten ersetzen werden, ist bislang… 
2010
2010
Retraction statement: Reconstitution of Plenaxis® (Abarelix) 100 mg for injection is more effective with a vortex-like mixer than when performed manually.
The article "Reconstitution of Plenaxis(®) (Abarelix) 100 mg for Injection is More Effective With a Vortex-Like Mixer Than When… 
2008
2008
Abarelix [Plenaxis] launched in Germany.
  • 2008
  • Corpus ID: 195104011
2005
2005
Five years' clinical use of GnRH antagonists: evaluation of safety and allergic potential.
Review
2004
Review
2004
Abarelix (Plenaxis): a gonadotropin-releasing hormone antagonist for medical castration in patients with advanced prostate cancer.
2004
2004
Abarelix (Plenaxis™) and Bevacizumab (Avastin®)
2004
2004
Abarelix (plenaxis).
2004
2004
Abarelix (Plenaxis) for advanced prostate cancer.
2003
2003
Encouraging results for Plenaxis in prostate cancer trial.
2003
2003
Gonadotropin releasing hormone antagonist, Plenaxis, receives US FDA approval
  • 2003
  • Corpus ID: 262639656
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)